Gait Disturbance as the Presenting Symptom in Young Children With Anti-NMDA Receptor Encephalitis

Anusha K Yeshokumar1, Lisa R Sun2, Jessica L Klein3

  • 1Division of Pediatric Neurology, and ayeshok1@jhmi.edu.

Pediatrics
|August 18, 2016
PubMed

Insights

Gait disturbance is an early sign of anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis in children under three. This finding aids in earlier diagnosis of this autoimmune encephalitis in toddlers.

Area of Science:

  • Pediatric Neurology
  • Neuroimmunology
  • Autoimmune Encephalitis

Background:

  • Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a significant cause of pediatric encephalitis, often presenting with speech and sleep disturbances.
  • While common in children, anti-NMDAR encephalitis is less frequently reported in infants and toddlers.
  • Early diagnosis and treatment are crucial but often delayed due to non-specific initial symptoms.

Observation:

  • This case series highlights a novel presentation of anti-NMDAR encephalitis in four children under three years old.
  • The primary initial symptom in all cases was gait disturbance, including unsteady walking and inability to bear weight.
  • Seizures and cerebellar ataxia-like symptoms were also noted at presentation.

Findings:

  • Gait disturbance, particularly in the context of other neurological signs, should prompt consideration of anti-NMDAR encephalitis in young children.
  • This contrasts with the more typical initial symptoms of disrupted speech and sleep patterns seen in older children.
  • The study identifies a specific early clinical phenotype in a rarely reported age group.

Implications:

  • Recognizing gait disturbance as an early indicator can lead to faster diagnosis and intervention for anti-NMDAR encephalitis in toddlers.
  • This expands the understanding of clinical variability in pediatric anti-NMDAR encephalitis.
  • Early diagnosis is critical for improving outcomes in this potentially severe autoimmune neurological condition.